Avid Bioservices Inc
NASDAQ:CDMO

Watchlist Manager
Avid Bioservices Inc Logo
Avid Bioservices Inc
NASDAQ:CDMO
Watchlist
Price: 12.28 USD -0.16%
Market Cap: 785.4m USD
Have any thoughts about
Avid Bioservices Inc?
Write Note

Avid Bioservices Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Avid Bioservices Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Avid Bioservices Inc
NASDAQ:CDMO
Revenue
$150.4m
CAGR 3-Years
12%
CAGR 5-Years
18%
CAGR 10-Years
21%
Abbvie Inc
NYSE:ABBV
Revenue
$55.5B
CAGR 3-Years
0%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$28.3B
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Revenue
$32.5B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$10.6B
CAGR 3-Years
14%
CAGR 5-Years
24%
CAGR 10-Years
30%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.8B
CAGR 3-Years
1%
CAGR 5-Years
16%
CAGR 10-Years
18%
No Stocks Found

Avid Bioservices Inc
Revenue Breakdown

Breakdown by Geography
Avid Bioservices Inc

Not Available

Breakdown by Segments
Avid Bioservices Inc

Total Revenue: 139.9m USD
100%
Manufacturing Revenues: 119.3m USD
85.3%
Process Development Revenues: 20.6m USD
14.7%

Avid Bioservices Inc
Glance View

Market Cap
785.4m USD
Industry
Biotechnology

Avid Bioservices, Inc. engages in the commercial manufacturing. The company is headquartered in Tustin, California and currently employs 252 full-time employees. The firm is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The firm provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The firm also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.

CDMO Intrinsic Value
17.56 USD
Undervaluation 30%
Intrinsic Value
Price

See Also

What is Avid Bioservices Inc's Revenue?
Revenue
150.4m USD

Based on the financial report for Oct 31, 2024, Avid Bioservices Inc's Revenue amounts to 150.4m USD.

What is Avid Bioservices Inc's Revenue growth rate?
Revenue CAGR 10Y
21%

Over the last year, the Revenue growth was -16%. The average annual Revenue growth rates for Avid Bioservices Inc have been 12% over the past three years , 18% over the past five years , and 21% over the past ten years .

Back to Top